Trial Profile
Safety and preliminary efficacy of three doses of LEO 43204 with ingenol mebutate in patients with actinic keratoses
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Ingenol disoxate (Primary) ; Ingenol mebutate
- Indications Actinic keratosis
- Focus Adverse reactions; First in man; Therapeutic Use
- Sponsors LEO Pharma
- 03 Nov 2015 New trial record
- 27 Oct 2015 Results published on-line British Journal of Dermatology